Dysplasia Epiphysealis Hemimelica Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: D0FA7AECF900EN
Market Monitor Global

Abstracts

Dysplasia epiphysealis hemimelica (DEH), commonly known as Trevor disease, is a rare non-hereditary epiphyseal disorder, which is characterized by localized overgrowth of osteochondral affecting one or more ossification centers or epiphyses.

This report contains market size and forecasts of Dysplasia Epiphysealis Hemimelica Treatment in Global, including the following market information:

Global Dysplasia Epiphysealis Hemimelica Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dysplasia Epiphysealis Hemimelica Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hip Replacement Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dysplasia Epiphysealis Hemimelica Treatment include Zimmer Biomet, AstraZeneca, Genentech, Pfizer, Johnson&Johnson, Novartis, Teva and Medacta, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dysplasia Epiphysealis Hemimelica Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dysplasia Epiphysealis Hemimelica Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dysplasia Epiphysealis Hemimelica Treatment Market Segment Percentages, by Type, 2021 (%)

• Hip Replacement Surgery
• Knee Replacement Surgery
• Surgical Excision of Mass with Preservation of the Joint

Global Dysplasia Epiphysealis Hemimelica Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dysplasia Epiphysealis Hemimelica Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Ambulatory Surgical Center
• Others

Global Dysplasia Epiphysealis Hemimelica Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dysplasia Epiphysealis Hemimelica Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dysplasia Epiphysealis Hemimelica Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dysplasia Epiphysealis Hemimelica Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Zimmer Biomet
• AstraZeneca
• Genentech
• Pfizer
• Johnson&Johnson
• Novartis
• Teva
• Medacta

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dysplasia Epiphysealis Hemimelica Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dysplasia Epiphysealis Hemimelica Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DYSPLASIA EPIPHYSEALIS HEMIMELICA TREATMENT OVERALL MARKET SIZE

2.1 Global Dysplasia Epiphysealis Hemimelica Treatment Market Size: 2021 VS 2028
2.2 Global Dysplasia Epiphysealis Hemimelica Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dysplasia Epiphysealis Hemimelica Treatment Players in Global Market
3.2 Top Global Dysplasia Epiphysealis Hemimelica Treatment Companies Ranked by Revenue
3.3 Global Dysplasia Epiphysealis Hemimelica Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dysplasia Epiphysealis Hemimelica Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dysplasia Epiphysealis Hemimelica Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dysplasia Epiphysealis Hemimelica Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Dysplasia Epiphysealis Hemimelica Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dysplasia Epiphysealis Hemimelica Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dysplasia Epiphysealis Hemimelica Treatment Market Size Markets, 2021 & 2028
  4.1.2 Hip Replacement Surgery
  4.1.3 Knee Replacement Surgery
  4.1.4 Surgical Excision of Mass with Preservation of the Joint
4.2 By Type - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue & Forecasts
  4.2.1 By Type - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Ambulatory Surgical Center
  5.1.4 Others
5.2 By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue & Forecasts
  5.2.1 By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2021 & 2028
6.2 By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue & Forecasts
  6.2.1 By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028
  6.3.2 US Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.3.3 Canada Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.3.4 Mexico Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028
  6.4.2 Germany Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.3 France Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.4 U.K. Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.5 Italy Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.6 Russia Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.4.8 Benelux Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028
  6.5.2 China Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.5.3 Japan Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.5.4 South Korea Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.5.6 India Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028
  6.6.2 Brazil Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.6.3 Argentina Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028
  6.7.2 Turkey Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.7.3 Israel Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028
  6.7.5 UAE Dysplasia Epiphysealis Hemimelica Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Zimmer Biomet
  7.1.1 Zimmer Biomet Corporate Summary
  7.1.2 Zimmer Biomet Business Overview
  7.1.3 Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.1.4 Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.1.5 Zimmer Biomet Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.2.4 AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Genentech
  7.3.1 Genentech Corporate Summary
  7.3.2 Genentech Business Overview
  7.3.3 Genentech Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.3.4 Genentech Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.3.5 Genentech Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.4.4 Pfizer Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Johnson&Johnson
  7.5.1 Johnson&Johnson Corporate Summary
  7.5.2 Johnson&Johnson Business Overview
  7.5.3 Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.5.4 Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson&Johnson Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.6.4 Novartis Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Teva
  7.7.1 Teva Corporate Summary
  7.7.2 Teva Business Overview
  7.7.3 Teva Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.7.4 Teva Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.7.5 Teva Key News
7.8 Medacta
  7.8.1 Medacta Corporate Summary
  7.8.2 Medacta Business Overview
  7.8.3 Medacta Dysplasia Epiphysealis Hemimelica Treatment Major Product Offerings
  7.8.4 Medacta Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global Market (2017-2022)
  7.8.5 Medacta Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dysplasia Epiphysealis Hemimelica Treatment Market Opportunities & Trends in Global Market
Table 2. Dysplasia Epiphysealis Hemimelica Treatment Market Drivers in Global Market
Table 3. Dysplasia Epiphysealis Hemimelica Treatment Market Restraints in Global Market
Table 4. Key Players of Dysplasia Epiphysealis Hemimelica Treatment in Global Market
Table 5. Top Dysplasia Epiphysealis Hemimelica Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dysplasia Epiphysealis Hemimelica Treatment Product Type
Table 9. List of Global Tier 1 Dysplasia Epiphysealis Hemimelica Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dysplasia Epiphysealis Hemimelica Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dysplasia Epiphysealis Hemimelica Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Zimmer Biomet Corporate Summary
Table 31. Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 32. Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 35. AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Genentech Corporate Summary
Table 37. Genentech Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 38. Genentech Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 41. Pfizer Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson&Johnson Corporate Summary
Table 43. Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 44. Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 47. Novartis Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Teva Corporate Summary
Table 49. Teva Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 50. Teva Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Medacta Corporate Summary
Table 52. Medacta Dysplasia Epiphysealis Hemimelica Treatment Product Offerings
Table 53. Medacta Dysplasia Epiphysealis Hemimelica Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dysplasia Epiphysealis Hemimelica Treatment Segment by Type in 2021
Figure 2. Dysplasia Epiphysealis Hemimelica Treatment Segment by Application in 2021
Figure 3. Global Dysplasia Epiphysealis Hemimelica Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dysplasia Epiphysealis Hemimelica Treatment Revenue in 2021
Figure 8. By Type - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 12. US Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 24. China Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dysplasia Epiphysealis Hemimelica Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genentech Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Medacta Dysplasia Epiphysealis Hemimelica Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)